{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:20:22Z","timestamp":1793686822783,"version":"4.5.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guizhou Provincial Science and Technology Projects","award":["ZK [2022] General 515"],"award-info":[{"award-number":["ZK [2022] General 515"]}]},{"name":"Guizhou Provincial Science and Technology Projects","award":["Platform and Talent [2020] 2202"],"award-info":[{"award-number":["Platform and Talent [2020] 2202"]}]},{"name":"Scientific Research Project of Guizhou Administration of Traditional Chinese Medicine and Ethnic Medicine","award":["QZYY-2021-103"],"award-info":[{"award-number":["QZYY-2021-103"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973835"],"award-info":[{"award-number":["81973835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Sj\u00f6gren\u2019s syndrome (SS) is an inflammatory autoimmune disease characterized by high levels of chronic lymphocyte infiltration. Differences and dysfunction in the gut microbiota and metabolites may be closely related to the pathogenesis of SS. The purpose of this study was to reveal the relationship between the gut microbiota and metabolome in NOD mice as a model of SS and the role of FuFang Runzaoling (FRZ), which is a clinically effective in treating SS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>NOD mice were gavaged with FRZ for 10 weeks. The ingested volume of drinking water, submandibular gland index, pathologic changes of the submandibular glands, and serum cytokines interleukin (IL)-6, IL-10, IL-17\u00a0A, and tumor necrosis factor-alpha (TNF-\u03b1) were determined. The roles of FRZ on gut microbiota and fecal metabolites were explored by 16\u00a0S rRNA gene sequencing and liquid chromatography-mass spectrometry (LC-MC), respectively. The correlation between them was determined by Pearson correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the model group, the drinking water volume of NOD mice treated with FRZ increased and the submandibular gland index decreased. FRZ effectively ameliorated lymphocyte infiltration in the small submandibular glands in mice. Serum levels of IL-6, TNF-\u03b1, and IL-17\u00a0A decreased, and IL-10 increased. The\n                      <jats:italic>Firmicutes<\/jats:italic>\n                      \/\n                      <jats:italic>Bacteroidetes<\/jats:italic>\n                      ratio in the FRZ treatment group was higher. FRZ significantly downregulated the relative abundance of the family\n                      <jats:italic>Bacteroidaceae<\/jats:italic>\n                      and genus\n                      <jats:italic>Bacteroides<\/jats:italic>\n                      , and significantly upregulated the relative abundance of genus\n                      <jats:italic>Lachnospiraceae_UCG-001<\/jats:italic>\n                      . Orthogonal projections to latent structures discriminant analysis (OPLS-DA) revealed the significant change in fecal metabolites after FRZ treatment. Based on criteria of OPLS-DA variable influence on projection\u2009&gt;\u20091,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05, and fragmentation score\u2009&gt;\u200950, a total of 109 metabolites in the FRZ-H group were differentially regulated (47 downregulated and 62 upregulated) compared to their expressions in the model group. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed enriched metabolic of sphingolipid metabolism, retrograde endocannabinoid signaling, GABAergic synapse, necroptosis, arginine biosynthesis, and metabolism of histidine, alanine, aspartate, and glutamate. Correlation analysis between gut microbiota and fecal metabolites suggested that the enriched bacteria were related to many key metabolites.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Taken together, we found FRZ could reduce the inflammatory responses in NOD mice by regulating the gut microbiota, fecal metabolites, and their correlation to emerge a therapeutic effect on mice with SS. This will lay the foundation for the further studies and applications of FRZ, and the use of gut microbiotas as drug targets to treat SS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-023-04017-5","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T05:01:59Z","timestamp":1686632519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gut microbiota combined with fecal metabolomics reveals the effects of FuFang Runzaoling on the microbial and metabolic profiles in NOD mouse model of Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1186","volume":"23","author":[{"given":"Changming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hufan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wukai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"issue":"1","key":"4017_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, Indiveri F, Puppo F. Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9\u201325","journal-title":"Clin Exp Med"},{"issue":"2","key":"4017_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","volume":"65","author":"O Bjordal","year":"2020","unstructured":"Bjordal O, Norheim KB, R\u00f8dahl E, Jonsson R, Omdal R. Primary Sj\u00f6gren\u2019s syndrome and the eye. Surv Ophthalmol. 2020;65(2):119\u201332","journal-title":"Surv Ophthalmol"},{"issue":"22","key":"4017_CR3","doi-asserted-by":"publisher","first-page":"8443","DOI":"10.3390\/ijms21228443","volume":"21","author":"J Moon","year":"2020","unstructured":"Moon J, Yoon CH, Choi SH, Kim MK. Can gut microbiota affect dry eye syndrome? Int J Mol Sci. 2020;21(22):8443","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4017_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jtos.2019.10.006","volume":"18","author":"CM Trujillo-Vargas","year":"2020","unstructured":"Trujillo-Vargas CM, Schaefer L, Alam J, Pflugfelder SC, Britton RA, de Paiva CS. The gut-eye-lacrimal gland-microbiome axis in Sj\u00f6gren Syndrome. Ocul Surf 2020;18(2):335\u201344","journal-title":"Ocul Surf"},{"key":"4017_CR5","doi-asserted-by":"publisher","first-page":"27194","DOI":"10.1038\/srep27194","volume":"6","author":"L Zhao","year":"2016","unstructured":"Zhao L, Dong M, Liao S, Du Y, Zhou Q, Zheng H, Chen M, Ji J, Gao H. Identification of key metabolic changes in renal interstitial fibrosis rats using metabonomics and pharmacology. Sci Rep. 2016;6:27194","journal-title":"Sci Rep"},{"issue":"1","key":"4017_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/mas.21553","volume":"38","author":"H Luan","year":"2019","unstructured":"Luan H, Wang X, Cai Z. Mass spectrometry-based metabolomics: targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders. Mass Spectrom Rev. 2019;38(1):22\u201333","journal-title":"Mass Spectrom Rev"},{"issue":"2","key":"4017_CR7","first-page":"43","volume":"40","author":"X Yuan","year":"2018","unstructured":"Yuan X, Hou L, Zeng P, Ma W. Clinical observation on 30 cases of Sjogren\u2019s syndrome treated by runzaoling decoction. J Guiyang Coll Tradit Chin Med. 2018;40(2):43\u20135.","journal-title":"J Guiyang Coll Traditional Chin Med"},{"issue":"12","key":"4017_CR8","first-page":"2190","volume":"25","author":"W Ma","year":"2010","unstructured":"Ma W, Zhong Q, Yao X, Liu Z, Tang F, An Y, Huang Y. Clinical observation on therapeutic effect of Miao traditional medicine Jinwujiangu Decoction on rheumatoid arthritis. Chin J Tradit Chin Med Pharm. 2010;25(12):2190\u20132.","journal-title":"Chin J Tradit Chin Med Pharm"},{"issue":"2","key":"4017_CR9","first-page":"43","volume":"40","author":"X Yuan","year":"2018","unstructured":"Yuan X, Hou L, Zeng P, Ma W. Observation on therapeutic effect of runzaoling for 30 cases of Sj\u00f6gren\u2019s syndrome. J Guiyang Univ Chin Med. 2018;40(2):43\u20135.","journal-title":"J Guiyang Univ Chin Med"},{"key":"4017_CR10","doi-asserted-by":"publisher","first-page":"7236118","DOI":"10.1155\/2022\/7236118","volume":"2022","author":"P Zeng","year":"2022","unstructured":"Zeng P, Jiang Z, Huang Z, Huang Y, Xu H, Chen C, Ma W. PI3K\/AKT\/mTOR signaling pathway is downregulated by runzaoling (RZL) in Sj\u00f6gren\u2019s Syndrome. Mediat Inflamm. 2022;2022:7236118","journal-title":"Mediat Inflamm"},{"issue":"4","key":"4017_CR11","first-page":"316","volume":"33","author":"E Jia","year":"2011","unstructured":"Jia E, Liu L, Yao X, Ma W. The influence of runzaoling on AQP1 and AQP5 in submaxillary gland of mice with Sj\u00f6gren\u2019s syndrome. Int J Trad Chin Med. 2011;33(4):316\u20138.","journal-title":"Int J Trad Chin Med"},{"issue":"4","key":"4017_CR12","first-page":"329","volume":"58","author":"W Ma","year":"2017","unstructured":"Ma W, Zeng P, He X, Ning Q, Yao X, Zhou J. Hou L. Effects of runzaoling recipe on serum Th1\/Th2 in Sj\u00f6gren\u2019s syndrome model mice. J Tradit Chin Med. 2017;58(4):329\u201333.","journal-title":"J Tradit Chin Med"},{"issue":"2","key":"4017_CR13","first-page":"158","volume":"33","author":"L Hou","year":"2017","unstructured":"Hou L, Zeng P, He X, Ning Q, Yao X, Zhou J, Ma W. Effects of Runzaoling on Th17\/Treg cells in Sj\u00f6gren\u2019s syndrome model mice. Pharmacol Clin o Chin Materia Med. 2017;33(2):158\u201362.","journal-title":"Pharmacol Clin o Chin Materia Med"},{"issue":"2","key":"4017_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J basic Clin Pharm. 2016;7(2):27\u201331","journal-title":"J basic Clin Pharm"},{"issue":"1","key":"4017_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, Bootsma H, De Vita S, D\u00f6rner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, et al. EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3\u201318","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4017_CR16","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","volume":"74","author":"X Lin","year":"2015","unstructured":"Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, Ko KH, Jiao Z, Chan VS, Lau CS, et al. Th17 cells play a critical role in the development of experimental Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2015;74(6):1302\u201310","journal-title":"Ann Rheum Dis"},{"issue":"D1","key":"4017_CR17","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587\u2013d592","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4017_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"4017_CR19","first-page":"354","volume":"114","author":"AL Stefanski","year":"2017","unstructured":"Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, D\u00f6rner T. The diagnosis and treatment of Sj\u00f6gren\u2019s Syndrome. Deutsches Arzteblatt Int. 2017;114(20):354\u201361.","journal-title":"Deutsches Arzteblatt Int"},{"issue":"7","key":"4017_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2012.53","volume":"8","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X, Tzioufas AG. Topical and systemic medications for the treatment of primary Sj\u00f6gren\u2019s syndrome. Nat Rev Rheumatol. 2012;8(7):399\u2013411","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"4017_CR21","first-page":"2912","volume":"35","author":"W Ma","year":"2017","unstructured":"Ma W, Zeng P, He X, Ning Q, Zhou J, Hou L. Study on Chinese medicine Runzaoling to submandibular gland of Sj\u00f6gren\u2019s syndrome model mice. Chin Archives Traditional Chin Med. 2017;35(11):2912\u20134.","journal-title":"Chin Archives Traditional Chin Med"},{"issue":"1","key":"4017_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10067-017-3821-4","volume":"37","author":"D Zhong","year":"2018","unstructured":"Zhong D, Wu C, Zeng X, Wang Q. The role of gut microbiota in the pathogenesis of rheumatic diseases. Clin Rheumatol. 2018;37(1):25\u201334","journal-title":"Clin Rheumatol"},{"key":"4017_CR23","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3389\/fimmu.2018.01106","volume":"9","author":"C Tsigalou","year":"2018","unstructured":"Tsigalou C, Stavropoulou E, Bezirtzoglou E. Current insights in Microbiome Shifts in Sjogren\u2019s syndrome and possible therapeutic interventions. Front Immunol. 2018;9:1106","journal-title":"Front Immunol"},{"issue":"1","key":"4017_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/CIRCRESAHA.118.313234","volume":"124","author":"E Brandsma","year":"2019","unstructured":"Brandsma E, Kloosterhuis NJ, Koster M, Dekker DC, Gijbels MJJ, van der Velden S, R\u00edos-Morales M, van Faassen MJR, Loreti MG, de Bruin A, et al. A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis. Circul Res. 2019;124(1):94\u2013100","journal-title":"Circul Res"},{"issue":"6","key":"4017_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/nu3060637","volume":"3","author":"A Hakansson","year":"2011","unstructured":"Hakansson A, Molin G. Gut microbiota and inflammation. Nutrients. 2011;3(6):637\u201382","journal-title":"Nutrients"},{"key":"4017_CR26","doi-asserted-by":"publisher","first-page":"23561","DOI":"10.1038\/srep23561","volume":"6","author":"CS de Paiva","year":"2016","unstructured":"de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, et al. Altered mucosal microbiome diversity and disease severity in Sj\u00f6gren syndrome. Sci Rep. 2016;6:23561","journal-title":"Sci Rep"},{"issue":"1","key":"4017_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13075-017-1446-2","volume":"19","author":"T Mandl","year":"2017","unstructured":"Mandl T, Marsal J, Olsson P, Ohlsson B, Andr\u00e9asson K. Severe intestinal dysbiosis is prevalent in primary Sj\u00f6gren\u2019s syndrome and is associated with systemic disease activity. Arthritis Res therapy. 2017;19(1):237","journal-title":"Arthritis Res therapy"},{"issue":"1","key":"4017_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/nyas.13736","volume":"1421","author":"C Bellocchi","year":"2018","unstructured":"Bellocchi C, Fern\u00e1ndez-Ochoa \u00c1, Montanelli G, Vigone B, Santaniello A, Milani C, Quirantes-Pin\u00e9 R, Borr\u00e1s-Linares I, Ventura M, Segura-Carrettero A, et al. Microbial and metabolic multi-omic correlations in systemic sclerosis patients. Ann N Y Acad Sci. 2018;1421(1):97\u2013109","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"4017_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12934-020-01348-7","volume":"19","author":"R Mendez","year":"2020","unstructured":"Mendez R, Watane A, Farhangi M, Cavuoto KM, Leith T, Budree S, Galor A, Banerjee S. Gut microbial dysbiosis in individuals with Sj\u00f6gren\u2019s syndrome. Microb Cell Fact. 2020;19(1):90","journal-title":"Microb Cell Fact"},{"issue":"6","key":"4017_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jop.12149","volume":"43","author":"TR de Souza","year":"2014","unstructured":"de Souza TR, de Albuquerque Tavares Carvalho A, Duarte \u00c2P, Porter SR, Le\u00e3o JC, Gueiros LA. Th1 and Th2 polymorphisms in Sj\u00f6gren\u2019s syndrome and rheumatoid arthritis. J oral Pathol Med: Public Int Assoc Oral Pathol Am Acad Oral Pathol. 2014;43(6):418\u201326","journal-title":"J oral Pathol Med: Public Int Assoc Oral Pathol Am Acad Oral Pathol"},{"issue":"1","key":"4017_CR31","doi-asserted-by":"publisher","first-page":"e20190418","DOI":"10.1084\/jem.20190418","volume":"217","author":"M Saraiva","year":"2020","unstructured":"Saraiva M, Vieira P, O\u2019Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020;217(1):e20190418","journal-title":"J Exp Med"},{"issue":"2","key":"4017_CR32","first-page":"1131","volume":"20","author":"J Qi","year":"2019","unstructured":"Qi J, Li D, Shi G, Zhang X, Pan Y, Dou H, Wang T, Yao G, Hou Y. Interleukin\u201312 exacerbates Sj\u00f6gren\u2019s syndrome through induction of myeloid\u2013derived suppressor cells. Mol Med Rep. 2019;20(2):1131\u20138","journal-title":"Mol Med Rep"},{"key":"4017_CR33","doi-asserted-by":"publisher","first-page":"102611","DOI":"10.1016\/j.jaut.2021.102611","volume":"119","author":"DS Kim","year":"2021","unstructured":"Kim DS, Woo JS, Min HK, Choi JW, Moon JH, Park MJ, Kwok SK, Park SH, Cho ML. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sj\u00f6gren\u2019s syndrome. J Autoimmun. 2021;119:102611","journal-title":"J Autoimmun"},{"issue":"4","key":"4017_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.immuni.2014.03.005","volume":"40","author":"Y Goto","year":"2014","unstructured":"Goto Y, Panea C, Nakato G, Cebula A, Lee C, Diez MG, Laufer TM, Ignatowicz L. Ivanov, II: segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity. 2014;40(4):594\u2013607","journal-title":"Immunity"},{"issue":"3","key":"4017_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/mi.2009.5","volume":"2","author":"CS De Paiva","year":"2009","unstructured":"De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD 3rd, Fang B, Zheng X, Ma P, Farley WJ, Siemasko KF, Niederkorn JY, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2009;2(3):243\u201353","journal-title":"Mucosal Immunol"},{"issue":"5","key":"4017_CR36","doi-asserted-by":"publisher","first-page":"e01548","DOI":"10.1128\/mBio.01548-14","volume":"5","author":"A Hevia","year":"2014","unstructured":"Hevia A, Milani C, L\u00f3pez P, Cuervo A, Arboleya S, Duranti S, Turroni F, Gonz\u00e1lez S, Su\u00e1rez A, Gueimonde M, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014;5(5):e01548\u201301514","journal-title":"mBio"},{"issue":"8","key":"4017_CR37","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895\u2013905","journal-title":"Nat Med"},{"issue":"3","key":"4017_CR38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/gbe\/evu050","volume":"6","author":"CJ Meehan","year":"2014","unstructured":"Meehan CJ, Beiko RG. A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria. Genome Biol Evol. 2014;6(3):703\u201313","journal-title":"Genome Biol Evol"},{"issue":"5","key":"4017_CR39","doi-asserted-by":"publisher","first-page":"e00073","DOI":"10.1128\/IAI.00073-18","volume":"86","author":"G Huang","year":"2018","unstructured":"Huang G, Zhang S, Zhou C, Tang X, Li C, Wang C, Tang X, Suo J, Jia Y, El-Ashram S, et al. Influence of Eimeria falciformis infection on gut microbiota and metabolic pathways in mice. Infect Immun. 2018;86(5):e00073","journal-title":"Infect Immun"},{"issue":"4","key":"4017_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/metabo10040133","volume":"10","author":"C Ceccarani","year":"2020","unstructured":"Ceccarani C, Bassanini G, Montanari C, Casiraghi MC, Ottaviano E, Morace G, Biasucci G, Paci S, Borghi E, Verduci E. Proteobacteria overgrowth and butyrate-producing taxa depletion in the gut microbiota of glycogen storage disease type 1 patients. Metabolites. 2020;10(4):133","journal-title":"Metabolites"},{"issue":"9","key":"4017_CR41","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.3390\/nu13093143","volume":"13","author":"M Yang","year":"2021","unstructured":"Yang M, Gu Y, Li L, Liu T, Song X, Sun Y, Cao X, Wang B, Jiang K, Cao H. Bile acid-gut microbiota axis in inflammatory bowel disease: from bench to bedside. Nutrients. 2021;13(9):3143.","journal-title":"Nutrients"},{"issue":"7","key":"4017_CR42","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.cell.2020.05.033","volume":"181","author":"CM Theriot","year":"2020","unstructured":"Theriot CM, Petri WA Jr. Role of microbiota-derived bile acids in enteric infections. Cell. 2020;181(7):1452\u20134","journal-title":"Cell"},{"issue":"2","key":"4017_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9(2):139\u201350","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"4017_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nri2974","volume":"11","author":"S Spiegel","year":"2011","unstructured":"Spiegel S, Milstien S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol. 2011;11(6):403\u201315","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"4017_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","volume":"9","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discovery. 2010;9(11):883\u201397","journal-title":"Nat Rev Drug Discovery"},{"issue":"7","key":"4017_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/gene.2014.48","volume":"15","author":"MM Zhang","year":"2014","unstructured":"Zhang MM, Jiang YS, Lv HC, Mu HB, Li J, Shang ZW, Zhang RJ. Pathway-based association analysis of two genome-wide screening data identifies rheumatoid arthritis-related pathways. Genes Immun. 2014;15(7):487\u201394","journal-title":"Genes Immun"},{"issue":"20","key":"4017_CR47","doi-asserted-by":"publisher","first-page":"e2021063118","DOI":"10.1073\/pnas.2021063118","volume":"118","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Zhang X, Liu J, He P, Zhang S, Zhang Y, Gao J, Yang S, Kang N, Afridi MI, et al. GABAergic synapses suppress intestinal innate immunity via insulin signaling in Caenorhabditis elegans. Proc Natl Acad Sci USA. 2021;118(20):e2021063118","journal-title":"Proc Natl Acad Sci USA"},{"key":"4017_CR48","doi-asserted-by":"publisher","first-page":"809806","DOI":"10.3389\/fimmu.2021.809806","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Jiang P, Guo S, Schrodi SJ, He D. Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis. Front Immunol. 2021;12:809806","journal-title":"Front Immunol"},{"issue":"6","key":"4017_CR49","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009;137(6):1112\u201323","journal-title":"Cell"},{"issue":"11","key":"4017_CR50","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1177\/0022034519869906","volume":"98","author":"MM Nascimento","year":"2019","unstructured":"Nascimento MM, Alvarez AJ, Huang X, Browngardt C, Jenkins R, Sinhoreti MC, Ribeiro APD, Dilbone DA, Richards VP, Garrett TJ, et al. Metabolic profile of Supragingival plaque exposed to arginine and fluoride. J Dent Res. 2019;98(11):1245\u201352","journal-title":"J Dent Res"},{"issue":"3","key":"4017_CR51","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/nu12030848","volume":"12","author":"M Hole\u010dek","year":"2020","unstructured":"Hole\u010dek M. Histidine in Health and Disease: metabolism, physiological importance, and use as a supplement. Nutrients. 2020;12(3):848","journal-title":"Nutrients"},{"key":"4017_CR52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.biocel.2017.05.004","volume":"88","author":"T Uemura","year":"2017","unstructured":"Uemura T, Suzuki T, Saiki R, Dohmae N, Ito S, Takahashi H, Toida T, Kashiwagi K, Igarashi K. Activation of MMP-9 activity by acrolein in saliva from patients with primary Sj\u00f6gren\u2019s syndrome and its mechanism. Int J Biochem Cell Biol. 2017;88:84\u201391","journal-title":"Int J Biochem Cell Biol"},{"issue":"Suppl 133","key":"4017_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.55563\/clinexprheumatol\/ylte6v","volume":"39","author":"T Xu","year":"2021","unstructured":"Xu T, Guo Y, Lu J, Shan J, Lin L, Qian W, Chen W, Wang J, Lv X, Ke M, et al. Untargeted serum metabolomics and potential biomarkers for Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2021;39(Suppl 133):23\u20139","journal-title":"Clin Exp Rheumatol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04017-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-04017-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04017-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T06:02:56Z","timestamp":1686636176000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-04017-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4017"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-04017-5","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Animal Ethics Committee of the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine (Ky2019012 and Ky20190107). The experiment was carried out in strict accordance with the international rules and regulations of laboratory animal ethics. The study was carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}